Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 502

1.

Dynamic changes in sRAGE levels and relationship with cardiac function in STEMI patients.

Jensen LJ, Lindberg S, Hoffmann S, Iversen AZ, Pedersen SH, Møgelvang R, Galatius S, Flyvbjerg A, Jensen JS, Bjerre M.

Clin Biochem. 2015 Jan 3. pii: S0009-9120(14)00822-4. doi: 10.1016/j.clinbiochem.2014.12.022. [Epub ahead of print]

PMID:
25562186
[PubMed - as supplied by publisher]
2.

Insufficient insulin administration to diabetic rats increases substrate utilization and maintains lactate production in the kidney.

Laustsen C, Lipsø K, Ostergaard JA, Nørregaard R, Flyvbjerg A, Pedersen M, Palm F, Ardenkjær-Larsen JH.

Physiol Rep. 2014 Dec 11;2(12). pii: e12233. doi: 10.14814/phy2.12233. Print 2014 Dec 1.

PMID:
25501426
[PubMed]
Free Article
3.

Osteoprotegerin levels change during STEMI and reflect cardiac function.

Lindberg S, Jensen JS, Hoffmann S, Iversen AZ, Pedersen SH, Mogelvang R, Galatius S, Flyvbjerg A, Bjerre M.

Can J Cardiol. 2014 Dec;30(12):1523-8. doi: 10.1016/j.cjca.2014.08.015. Epub 2014 Aug 23.

PMID:
25475457
[PubMed - indexed for MEDLINE]
4.

Low adiponectin levels and increased risk of type 2 diabetes in patients with myocardial infarction.

Lindberg S, Jensen JS, Pedersen SH, Galatius S, Frystyk J, Flyvbjerg A, Bjerre M, Mogelvang R.

Diabetes Care. 2014 Nov;37(11):3003-8. doi: 10.2337/dc14-0932. Epub 2014 Jul 30.

PMID:
25078899
[PubMed - in process]
5.

Association of the pattern recognition molecule H-ficolin with incident microalbuminuria in an inception cohort of newly diagnosed type 1 diabetic patients: an 18 year follow-up study.

Østergaard JA, Thiel S, Hovind P, Holt CB, Parving HH, Flyvbjerg A, Rossing P, Hansen TK.

Diabetologia. 2014 Oct;57(10):2201-7. doi: 10.1007/s00125-014-3332-7. Epub 2014 Jul 28.

PMID:
25064124
[PubMed - in process]
6.

Osteoprotegerin independently predicts mortality in patients with stable coronary artery disease: the CLARICOR trial.

Bjerre M, Hilden J, Kastrup J, Skoog M, Hansen JF, Kolmos HJ, Jensen GB, Kjøller E, Winkel P, Flyvbjerg A, Gluud C; Claricor Trial Group.

Scand J Clin Lab Invest. 2014 Nov;74(8):657-64. doi: 10.3109/00365513.2014.930510. Epub 2014 Jul 15.

PMID:
25026506
[PubMed - in process]
7.

Plasma neutrophil gelatinase-associated lipocalinin in the general population: association with inflammation and prognosis.

Lindberg S, Jensen JS, Mogelvang R, Pedersen SH, Galatius S, Flyvbjerg A, Magnusson NE.

Arterioscler Thromb Vasc Biol. 2014 Sep;34(9):2135-42. doi: 10.1161/ATVBAHA.114.303950. Epub 2014 Jun 26.

PMID:
24969771
[PubMed - indexed for MEDLINE]
8.

Osteopontin is a strong predictor of incipient diabetic nephropathy, cardiovascular disease, and all-cause mortality in patients with type 1 diabetes.

Gordin D, Forsblom C, Panduru NM, Thomas MC, Bjerre M, Soro-Paavonen A, Tolonen N, Sandholm N, Flyvbjerg A, Harjutsalo V, Groop PH; FinnDiane Study Group.

Diabetes Care. 2014 Sep;37(9):2593-600. doi: 10.2337/dc14-0065. Epub 2014 Jun 26.

PMID:
24969575
[PubMed - in process]
9.

Body mass index is related to microvascular vasomotion, this is partly explained by adiponectin.

de Boer MP, Wijnstok NJ, Serné EH, Eringa EC, Stehouwer CD, Flyvbjerg A, Hoekstra T, Heymans MW, Meijer RI, Twisk JW, Smulders YM.

Eur J Clin Invest. 2014 Jul;44(7):660-7. doi: 10.1111/eci.12284.

PMID:
24854850
[PubMed - in process]
10.

A protocol for a randomised, double-blind, placebo-controlled study of the effect of LIraglutide on left VEntricular function in chronic heart failure patients with and without type 2 diabetes (The LIVE Study).

Jorsal A, Wiggers H, Holmager P, Nilsson B, Nielsen R, Boesgaard TW, Kumme A, Møller JE, Videbæk L, Kistorp C, Gustafsson I, Tarnow L, Flyvbjerg A.

BMJ Open. 2014 May 20;4(5):e004885. doi: 10.1136/bmjopen-2014-004885.

PMID:
24844271
[PubMed - in process]
Free PMC Article
11.

Diabetic kidney disease: a clinical update from Kidney Disease: Improving Global Outcomes.

Molitch ME, Adler AI, Flyvbjerg A, Nelson RG, So WY, Wanner C, Kasiske BL, Wheeler DC, de Zeeuw D, Mogensen CE.

Kidney Int. 2015 Jan;87(1):20-30. doi: 10.1038/ki.2014.128. Epub 2014 Apr 30.

PMID:
24786708
[PubMed - in process]
12.

High osteoprotegerin levels predict MACCE in STEMI patients, but are not associated with myocardial salvage.

Bjerre M, Munk K, Sloth AD, Nielsen SS, Flyvbjerg A, Bøtker HE.

Scand Cardiovasc J. 2014 Aug;48(4):209-15. doi: 10.3109/14017431.2014.917767. Epub 2014 May 28.

PMID:
24758546
[PubMed - in process]
13.

Cardio-adipose tissue cross-talk: relationship between adiponectin, plasma pro brain natriuretic peptide and incident heart failure.

Lindberg S, Jensen JS, Bjerre M, Pedersen SH, Frystyk J, Flyvbjerg A, Mogelvang R.

Eur J Heart Fail. 2014 Jun;16(6):633-8. doi: 10.1002/ejhf.82. Epub 2014 Apr 10.

PMID:
24723498
[PubMed - indexed for MEDLINE]
14.

Making sense of chromogranin A in heart disease.

Goetze JP, Alehagen U, Flyvbjerg A, Rehfeld JF.

Lancet Diabetes Endocrinol. 2013 Sep;1(1):7-8. doi: 10.1016/S2213-8587(13)70035-4. Epub 2013 Jun 13. Review. No abstract available.

PMID:
24622255
[PubMed - indexed for MEDLINE]
15.

Effects of long-acting somatostatin analogues on redox systems in rat lens in experimental diabetes.

Kunjara S, Greenbaum AL, Sochor M, Flyvbjerg A, Grønbaek H, McLean P.

Int J Exp Pathol. 2014 Apr;95(2):95-100. doi: 10.1111/iep.12069. Epub 2014 Mar 6.

PMID:
24602114
[PubMed - indexed for MEDLINE]
16.

High altitude may alter oxygen availability and renal metabolism in diabetics as measured by hyperpolarized [1-(13)C]pyruvate magnetic resonance imaging.

Laustsen C, Lycke S, Palm F, Østergaard JA, Bibby BM, Nørregaard R, Flyvbjerg A, Pedersen M, Ardenkjaer-Larsen JH.

Kidney Int. 2014 Jul;86(1):67-74. doi: 10.1038/ki.2013.504. Epub 2013 Dec 18.

PMID:
24352155
[PubMed - in process]
17.

Chromogranin A as a biomarker in cardiovascular disease.

Goetze JP, Alehagen U, Flyvbjerg A, Rehfeld JF.

Biomark Med. 2014;8(1):133-40. doi: 10.2217/bmm.13.102. Review.

PMID:
24325234
[PubMed - indexed for MEDLINE]
18.

Adiponectin, type 2 diabetes and cardiovascular risk.

Lindberg S, Jensen JS, Bjerre M, Pedersen SH, Frystyk J, Flyvbjerg A, Galatius S, Jeppesen J, Mogelvang R.

Eur J Prev Cardiol. 2015 Mar;22(3):276-83. doi: 10.1177/2047487313514894. Epub 2013 Nov 21.

PMID:
24265290
[PubMed - in process]
19.

Insulin growth factor binding proteins as therapeutic targets in type 2 diabetes.

Hjortebjerg R, Flyvbjerg A, Frystyk J.

Expert Opin Ther Targets. 2014 Feb;18(2):209-24. doi: 10.1517/14728222.2014.858698. Epub 2013 Nov 21. Review.

PMID:
24261835
[PubMed - indexed for MEDLINE]
20.

Glyoxalase-1 overexpression reduces endothelial dysfunction and attenuates early renal impairment in a rat model of diabetes.

Brouwers O, Niessen PM, Miyata T, Østergaard JA, Flyvbjerg A, Peutz-Kootstra CJ, Sieber J, Mundel PH, Brownlee M, Janssen BJ, De Mey JG, Stehouwer CD, Schalkwijk CG.

Diabetologia. 2014 Jan;57(1):224-35. doi: 10.1007/s00125-013-3088-5. Epub 2013 Oct 26.

PMID:
24162587
[PubMed - indexed for MEDLINE]
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk